Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
NCT00096915
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Disease
Chronic Kidney Disease
Interventions
DRUG:
Darbepoetin Alfa
Sponsor
Amgen